Zoledronate in Treating Bone Marrow Micrometastases in Women With Stage I, Stage II, or Stage III Breast Cancer
Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Zoledronate may delay or prevent bone marrow metastases in patients with breast
cancer.
PURPOSE: This phase II trial is studying how well zoledronate works in treating bone marrow
micrometastases in women with stage I, stage II, or stage III breast cancer.